We serve Chemical Name:2,2-Dibromomalonamide CAS:73003-80-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,2-Dibromomalonamide
CAS.NO:73003-80-2
Synonyms:dibromo-malonic acid diamide;Dibromomalonic Diamide;2,2-dibromomalonic diamide;Dibromomalonamide;MFCD00014803;Dibrom-malonsaeure-diamid;dibrommalonic diamide;2,2-Dibromomalonamide;EINECS 277-205-9;Propanediamide, 2,2-dibromo-
Molecular Formula:C3H4Br2N2O2
Molecular Weight:259.884
HS Code:2924199090
Physical and Chemical Properties:
Melting point:202-203°C
Boiling point:294.3±40.0 °C at 760 mmHg
Density:2.5±0.1 g/cm3
Index of Refraction:1.646
PSA:86.18000
Exact Mass:257.863922
LogP:0.76
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like dibromo-malonic acid diamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propanediamide, 2,2-dibromo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2-dibromomalonic diamide Use and application,Dibromomalonic Diamide technical grade,usp/ep/jp grade.
Related News: An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 2,2-Dibromomalonamide manufacturer The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 2,2-Dibromomalonamide supplier Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%. 2,2-Dibromomalonamide vendor The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 2,2-Dibromomalonamide factory An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.
